Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Olubukayo-Opeyemi Oyetayo"'
Autor:
Zheng Guan, Olubukayo-Opeyemi Oyetayo, Jules A. A. C. Heuberger, Joop M. A. van Gerven, Jasper Stevens, Linda E. Klumpers
Publikováno v:
British Journal of Clinical Pharmacology. 81:713-723
Aim: The severe psychiatric side effects of cannabinoid receptor type 1 (CB1) antagonists hampered their wide development but this might be overcome by careful management of drug development with pharmacokinetic/pharmacodynamic (PK/PD) analyses. PK/P
Publikováno v:
International journal of pharmaceutics. 530(1-2)
pH shift-induced aggregation is frequently observed in downstream processing of monoclonal antibodies and has been shown to depend on solvent composition. To quantify the stabilizing effect of polyol additives against aggregation, we determined aggre
Autor:
Jules A. A. C. Heuberger, Jan Freijer, Paul D. Morrison, Olubukayo-Opeyemi Oyetayo, Zheng Guan, Tim L. Beumer, Adam F. Cohen, Linda E. Klumpers, Joop M. A. van Gerven
Publikováno v:
Clinical Pharmacokinetics, 54(2), 209-219
Δ(9)-Tetrahydrocannobinol (THC), the main psychoactive compound of Cannabis, is known to have a long terminal half-life. However, this characteristic is often ignored in pharmacokinetic (PK) studies of THC, which may affect the accuracy of predictio
Autor:
Olubukayo-Opeyemi Oyetayo, Hans Kiefer
Publikováno v:
Pharmaceutical research. 33(6)
To present a convenient screening method for evaluating additive effects on the renaturation of an acid-exposed monoclonal antibody (mAb). The assay involves brief incubation of a mAb at acidic pH and subsequent neutralization in the absence or prese